A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Mar 2016
At a glance
- Drugs Indoximod (Primary) ; Docetaxel; Paclitaxel
- Indications Advanced breast cancer; Male breast cancer
- Focus Therapeutic Use
- Sponsors NewLink Genetics Corporation
- 12 Dec 2015 Preliminary results (n=65) presented at the 38th Annual San Antonio Breast Cancer Symposium.
- 10 Dec 2015 Preliminary results published in a NewLink Genetics Corporation media release.
- 10 Dec 2015 Status changed from recruiting to active, no longer recruiting according to a NewLink Genetics Corporation media release.